Trial of Otelixizumab for Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-1

PHASE3CompletedINTERVENTIONAL
Enrollment

272

Participants

Timeline

Start Date

July 29, 2008

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Diabetes Mellitus, Type 1
Interventions
BIOLOGICAL

otelixizumab infusion plus physician determined standard of care

infusion

BIOLOGICAL

placebo infusion plus physician determined standard of care

infusion

Trial Locations (109)

8000

GSK Investigational Site, Arhus C

8035

GSK Investigational Site, Barcelona

10032

GSK Investigational Site, New York

11501

GSK Investigational Site, Mineola

12200

GSK Investigational Site, Berlin

14209

GSK Investigational Site, Buffalo

14642

GSK Investigational Site, Rochester

19047

GSK Investigational Site, Langhorne

19140

GSK Investigational Site, Philadelphia

20037

GSK Investigational Site, Washington D.C.

20132

GSK Investigational Site, Milan

20520

GSK Investigational Site, Turku

21201

GSK Investigational Site, Baltimore

21287

GSK Investigational Site, Atlanta

27713

GSK Investigational Site, Durham

28040

GSK Investigational Site, Madrid

30309

GSK Investigational Site, Atlanta

30342

GSK Investigational Site, Atlanta

32789

GSK Investigational Site, Winter Park

32803

GSK Investigational Site, Orlando

32835

GSK Investigational Site, Orlando

33024

GSK Investigational Site, Pembroke Pines

33136

GSK Investigational Site, Miami

33169

GSK Investigational Site, Miami

33458

GSK Investigational Site, Jupiter

33486

GSK Investigational Site, Boca Raton

33520

GSK Investigational Site, Tampere

34655

GSK Investigational Site, Trinity

35294

GSK Investigational Site, Birmingham

37212

GSK Investigational Site, Nashville

37403

GSK Investigational Site, Chattanooga

37431

GSK Investigational Site, Bad Lauterberg im Harz

38119

GSK Investigational Site, Memphis

39501

GSK Investigational Site, Gulfport

43205

GSK Investigational Site, Columbus

43210

GSK Investigational Site, Columbus

44060

GSK Investigational Site, Mentor

46260

GSK Investigational Site, Indianapolis

48201

GSK Investigational Site, Detroit

49048

GSK Investigational Site, Kalamazoo

57701

GSK Investigational Site, Rapid City

60612

GSK Investigational Site, Chicago

60637

GSK Investigational Site, Chicago

61231

GSK Investigational Site, Bad Nauheim

63110

GSK Investigational Site, St Louis

64106

GSK Investigational Site, Kansas City

65212

GSK Investigational Site, Columbia

66606

GSK Investigational Site, Topeka

68131

GSK Investigational Site, Omaha

69120

GSK Investigational Site, Heidelberg

72205

GSK Investigational Site, Little Rock

75231

GSK Investigational Site, Dallas

75390

GSK Investigational Site, Dallas

76054

GSK Investigational Site, Hurst

77030

GSK Investigational Site, Houston

78229

GSK Investigational Site, San Antonio

80045

GSK Investigational Site, Aurora

83702

GSK Investigational Site, Boise

84403

GSK Investigational Site, Ogden

90033

GSK Investigational Site, Los Angeles

90127

GSK Investigational Site, Palermo

90502

GSK Investigational Site, Torrance

92506

GSK Investigational Site, Riverside

92626

GSK Investigational Site, Costa Mesa

92705

GSK Investigational Site, Santa Ana

92868

GSK Investigational Site, Orange

94598

GSK Investigational Site, Walnut Creek

96813

GSK Investigational Site, Honolulu

97210

GSK Investigational Site, Portland

97401

GSK Investigational Site, Eugene

98405

GSK Investigational Site, Tacoma

782154

GSK Investigational Site, Schertz

83404-7542

GSK Investigational Site, Idaho Falls

01655-0002

GSK Investigational Site, Worcester

07753

GSK Investigational Site, Neptune City

45415-2560

GSK Investigational Site, Dayton

74136-8303

GSK Investigational Site, Tulsa

29425-6240

GSK Investigational Site, Charleston

T2H 2G4

GSK Investigational Site, Calgary

L6H 3P1

GSK Investigational Site, Oakville

K7A 4W8

GSK Investigational Site, Smiths Falls

M4G 3E8

GSK Investigational Site, Toronto

H2W 1T8

GSK Investigational Site, Montreal

H9R 3J1

GSK Investigational Site, Pointe-Claire

04100

GSK Investigational Site, Latina

00157

GSK Investigational Site, Rome

00161

GSK Investigational Site, Rome

00168

GSK Investigational Site, Rome

09042

GSK Investigational Site, Monserrato

00128

GSK Investigational Site, Roma

Unknown

GSK Investigational Site, Girona

´03550

GSK Investigational Site, Sant Joan

08221

GSK Investigational Site, Tarrasa, Barcelona

SE-413 45

GSK Investigational Site, Gothenburg

SE-301 85

GSK Investigational Site, Halmstad

871 82

GSK Investigational Site, Härnösand

SE- 371 85

GSK Investigational Site, Karlskrona

SE-651 85

GSK Investigational Site, Karlstad

291 85

GSK Investigational Site, Kristianstad

SE-591 85

GSK Investigational Site, Motala

SE-171 76

GSK Investigational Site, Stockholm

SE-901 85

GSK Investigational Site, Umeå

SE-351 85

GSK Investigational Site, Vaxjo

BA1 3NG

GSK Investigational Site, Bath

BB2 3HH

GSK Investigational Site, Blackburn

BS2 8HW

GSK Investigational Site, Bristol

HU3 2RW

GSK Investigational Site, Hull

SE1 9RT

GSK Investigational Site, London

NE1 4LP

GSK Investigational Site, Newcastle upon Tyne

Sponsors
All Listed Sponsors
collaborator

Juvenile Diabetes Research Foundation

OTHER

lead

GlaxoSmithKline

INDUSTRY